David York Mason

Q: What Schools Are Affiliated With David York Mason

David York Mason is affiliated with the following schools: University of Sydney, University of Oxford, KU Leuven, University of Perugia

David York Mason's AcademicInfluence.com Rankings

David York Mason

Philosophy

#5106

World Rank

#7831

Historical Rank

Logic

#2438

World Rank

#3428

Historical Rank

philosophy Degrees

David York Mason

Biology

#6805

World Rank

#9603

Historical Rank

Immunology

#355

World Rank

#369

Historical Rank

Biochemistry

#896

World Rank

#1004

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

David York Mason's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is David York Mason Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David York Mason's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). (1984) (3311)
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. (1985) (1836)
Transferrin receptor on endothelium of brain capillaries (1984) (952)
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. (1990) (647)
bcl-2 protein in non-small-cell lung carcinoma. (1993) (607)
Transferrin receptors in human tissues: their distribution and possible clinical relevance. (1983) (539)
Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data (1992) (516)
Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis (1991) (481)
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody (1979) (463)
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. (1990) (443)
Identification of Hodgkin and sternberg‐reed cells as a unique cell type derived from a newly‐detected small‐cell population (1982) (414)
Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. (1978) (399)
Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes (1992) (387)
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. (1983) (370)
Ultrastructural localization of bcl-2 protein. (1992) (364)
The normal and malignant germinal centre. (1982) (350)
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. (1988) (344)
MALIGNANT HISTIOCYTOSIS OF THE INTESTINE: A T-CELL LYMPHOMA (1985) (343)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. (2006) (283)
Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. (1984) (280)
HUMAN LYMPHOID CELLS EXPRESS EPITHELIAL MEMBRANE ANTIGEN Implications for Diagnosis of Human Neoplasms (1984) (280)
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis (1983) (280)
A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily (1993) (259)
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. (1983) (256)
Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. (1983) (246)
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy (1982) (227)
Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. (1992) (220)
Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors (2000) (217)
Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. (1985) (214)
Novel markers of normal and neoplastic human plasmacytoid dendritic cells. (2008) (207)
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. (2002) (204)
Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. (1994) (204)
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. (1985) (198)
REARRANGEMENT OF THE T-CELL-RECEPTOR β-CHAIN GENE IN THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISORDERS (1985) (188)
New sites of human S-100 immunoreactivity detected with monoclonal antibodies. (1986) (183)
Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. (1986) (178)
IMMUNOCYTOCHEMICAL DETECTION OF T AND B CELL POPULATIONS IN ROUTINE BLOOD SMEARS (1984) (175)
A human macrophage‐associated antigen (CD68) detected by six different monoclonal antibodies (1989) (169)
Monoclonal Antibody to Human Platelet Glycoprotein I I. IMMUNOLOGICAL STUDIES (1981) (167)
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. (1986) (164)
Malignant histiocytosis a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies (1990) (163)
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen (1992) (158)
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. (2007) (158)
CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. (1995) (157)
The plasmacytoid monocyte/interferon producing cells (2003) (155)
The expression of major histocompatibility antigens by human chorionic villi. (1981) (155)
Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. (1988) (152)
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. (2007) (150)
The immunocytochemical detection of axillary micrometastases in breast cancer. (1984) (149)
Molecular Characterization of a New ALK Translocation Involving Moesin (MSN-ALK) in Anaplastic Large Cell Lymphoma (2001) (148)
Double Immunoenzymatic Labelling (1983) (145)
Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. (1992) (143)
Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. (1990) (143)
The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens (1988) (139)
The structure of the human CD2 gene and its expression in transgenic mice. (1988) (138)
CLINICAL IMPORTANCE OF ANALYSING MALIGNANT TUMOURS OF UNCERTAIN ORIGIN WITH IMMUNOHISTOLOGICAL TECHNIQUES (1985) (132)
Human dendritic reticulum cells of lymphoid follicles: Their antigenic profile and their identification as multinucleated giant cells (1983) (131)
The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. (1991) (127)
Genotypic analysis of large cell lymphomas which express the Ki‐1 antigen (1987) (122)
Expression of TAL-1 proteins in human tissues. (1995) (121)
An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. (1985) (120)
The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction (1990) (117)
New approach to assessing lung tumours in man. (1986) (111)
Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. (1998) (111)
Human complement (C3b) receptors defined by a mouse monoclonal antibody. (1982) (111)
Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. (2003) (108)
HLA-DR positive cells in the human placenta. (1983) (107)
Double immunofluorescence labelling of routinely processed paraffin sections (2000) (107)
Preparation of peroxidase: antiperoxidase (PAP) complexes for immunohistological labeling of monoclonal antibodies. (1982) (106)
Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study (1990) (106)
A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. (1985) (105)
Langerhans’cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia (1983) (105)
Langerhans' cells and T cells in human skin tumours: an immunohistological study (1984) (102)
CD30 expression in non‐Hodgkin's lymphoma (1990) (102)
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity. (2002) (100)
Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. (1989) (98)
Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. (1985) (97)
Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. (1992) (97)
Kupffer cell staining by an HFE‐specific monoclonal antibody: implications for hereditary haemochromatosis (1998) (95)
Ki‐67 immunostaining and survival in operable lung cancer (1991) (95)
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation (2010) (95)
PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. (2006) (94)
The value of immunohistological screening in the production of monoclonal antibodies. (1982) (94)
The Immunophenotyping of Extramedullary Myeloid Cell Tumors in Paraffin‐Embedded Tissue Sections (1988) (94)
An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. (1986) (93)
APAAP LABELLING OF BLOOD AND BONE-MARROW SAMPLES FOR PHENOTYPING LEUKAEMIA (1986) (90)
Human lung tumours may coexpress different classes of intermediate filaments. (1986) (90)
The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. (1984) (90)
Genotypic analysis of cutaneous T-cell lymphomas. (1987) (90)
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) (1994) (88)
An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel (1984) (86)
Anaplastic large‐cell lymphomas of B‐cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B‐cell lymphomas (2000) (86)
Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. (1986) (86)
Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. (1990) (85)
Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. (1986) (83)
Detection of three common translocation breakpoints in non‐Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin‐embedded tissue sections (2002) (83)
Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. (1985) (82)
The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. (1997) (82)
Evidence for the detection of the normal counterpart of hodgkin and sternberg‐reed cells (2007) (82)
Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization (1984) (82)
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (2005) (80)
The role of immunocytochemistry in diagnostic pathology. (1987) (80)
The labeled antigen method of immunoenzymatic staining. (1979) (80)
Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation (1990) (74)
Immature sinus histiocytes. Their identification as a novel B-cell population. (1984) (72)
Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. (1988) (71)
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. (1997) (71)
HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. (1991) (70)
Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. (1992) (69)
Cytokeratin expression in smooth muscle and smooth muscle tumours (1987) (68)
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. (2004) (68)
A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. (1986) (66)
Detection of cells of megakaryocyte lineage in haematological malignancies by immuno‐alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies (1987) (66)
Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67 (1993) (65)
Isolation and immunocytochemical characterization of human bone marrow stromal macrophages in hemopoietic clusters (1988) (63)
Cells bearing class II MHC antigens in the human placenta and amniochorion. (1986) (62)
Osteoclasts contain macrophage and megakaryocyte antigens (1986) (61)
Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. (1988) (61)
Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies (2007) (61)
The membrane IgM-associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb-1 gene. (1991) (61)
The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells (1979) (60)
Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. (1989) (60)
A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues. (1983) (60)
The B29 and mb‐1 polypeptides are differentially expressed during human B cell differentiation (1992) (59)
CELL LINEAGE IN HODGKIN'S DISEASE (1987) (59)
BTG1: a triiodothyronine target involved in the myogenic influence of the hormone. (1999) (58)
The structure of the μ/pseudo light chain complex on human pre‐B cells is consistent with a function in signal transduction (1993) (57)
Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens. (1988) (57)
Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. (1988) (56)
Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily (1999) (54)
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells (1987) (53)
Combined immunophenotyping and FISH identifies the involvement of B‐cells in 5q‐ syndrome (2000) (52)
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples (2003) (51)
Comparison of human B cell antigen receptor complexes: membrane- expressed forms of immunoglobulin (Ig)M, IgD, and IgG are associated with structurally related heterodimers (1992) (51)
Different isoforms of human FcRII distinguished by CDw32 antibodies. (1990) (50)
Diffuse follicular lymphoid hyperplasia of the small intestine without primary immunoglobulin deficiency. (1982) (50)
An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. (1993) (49)
Antigen Receptors on T and B Lymphocytes: Parallels in Organization and Function (1993) (48)
Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high‐grade non‐Hodgkin's lymphoma (1995) (48)
FREEZE-DRIED PARAFFIN-EMBEDDED HUMAN TISSUE FOR ANTIGEN LABELLING WITH MONOCLONAL ANTIBODIES (1984) (47)
Heterogeneity of bcl‐2 expression in MALT lymphoma (1995) (47)
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. (2006) (47)
The expression of the CD3 antigen in Hodgkin's disease (1989) (46)
ALPHA-CHAIN DISEASE: EVIDENCE FOR COMMON CLONAL ORIGIN OF INTESTINAL IMMUNOBLASTIC LYMPHOMA AND PLASMACYTIC PROLIFERATION (1977) (45)
Langerhans' cells in human cervical epithelium: an immunohistological study. (1984) (44)
Immunoalkaline phosphatase labeling of terminal transferase in hematologic samples. (1987) (44)
The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas (1989) (44)
Transmembrane adaptor molecules: a new category of lymphoid-cell markers. (2006) (43)
Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases (1986) (43)
Detection of NPM‐ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma (1995) (42)
Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. (1991) (42)
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. (1984) (42)
Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies (1984) (42)
Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies. (1985) (42)
The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). (2004) (41)
Expression of intermediate filament proteins in normal and diseased thyroid glands. (1987) (41)
mb-1: A New Marker for B-Lineage Lymphoblastic Leukemia (1993) (41)
Intracellular lysozyme and lactoferrin in myeloproliferative disorders. (1977) (41)
Expression of the interleukin-2 receptor (Tac antigen/CD25) in hematologic neoplasms. (1988) (40)
Erythrocyte Glutathione Peroxidase Content and Serum Tocopherol Levels in Newborn Infants (1972) (39)
Immunohistochemical study of mammary and extra‐mammary Paget's disease (1984) (38)
T‐cell origin of Lennert's lymphoma (1986) (38)
Clonal silencing of self-reactive B lymphocytes in a transgenic mouse model. (1989) (37)
Epithelial membrane antigen in hematopoietic neoplasms. (1986) (37)
Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. (1993) (37)
Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies (1984) (37)
Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. (1988) (36)
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. (2004) (35)
Cellular distribution of human leucocyte adhesion molecule ICAM-3. (1994) (35)
Is it necessary to embed bone marrow biopsies in plastic for haematological diagnosis? (1987) (33)
Detection of metastatic tumour cells in routine bone marrow smears by immuno‐alkaline phosphatase labelling with monoclonal antibodies (1985) (33)
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. (2003) (33)
Relationship between Paraprotein Polymerization and Clinical Features in IgA Myeloma (1976) (32)
Immunophenotyping of acute myeloid leukemia by immuno‐alkaline phosphatase (APAAP) labeling with a panel of antibodies (1987) (32)
Anaplastic lymphoma kinase proteins and malignancy (2001) (32)
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach (2008) (32)
Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. (1985) (31)
Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates. (1986) (31)
The FOXP 1 Winged Helix Transcription Factor Is a Novel Candidate Tumor Suppressor Gene on Chromosome 3 p 1 (2001) (30)
Langerhans cells in human lung tumours: an immunohistological study (1989) (30)
Monoclonal antibody patterns in lymphomatoid papulosis. (1985) (30)
Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. (1984) (30)
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells (2004) (30)
CD 30 expression in follicular lymphoma (1991) (29)
Primary Acquired Sideroblastic Anaemia: Response to Treatment with Pyridoxal-5-Phosphate (1973) (28)
Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody (2010) (27)
Biochemical evidence that cytokeratins are present in smooth muscle. (1988) (27)
CD68 reactivity of non-macrophage derived tumours in cytological specimens. (1993) (27)
BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations (2009) (26)
Evidence of Sternberg-Reed cells being derived from activated lymphocytes. (1985) (25)
Practical value of genotypic analysis for diagnosing lymphoproliferative disorders. (1987) (25)
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples (2004) (25)
Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates (2004) (24)
DETECTION OF 14;18 CHROMOSOMAL TRANSLOCATION IN PARAFFIN-EMBEDDED LYMPHOMA TISSUE (1989) (24)
Rapid preparation of peroxidase: anti-peroxidase complexes for immunocytochemical use. (1978) (23)
Human Leucocyte Differentiation Antigen nomenclature: update on CD nomenclature. Report of IUIS/WHO Subcommittee. (2003) (23)
Antibody By 114 is selective for the 90 kD PI‐linked component of the CD66 antigen: a new reagent for the study of paroxysmal nocturnal haemoglobinuria (1993) (23)
Reactive and neoplastic human lymphoid cells producing J chain in the absence of immunoglobulin: evidence for the existence of 'J chain disease'? (1981) (23)
Human Lymphoma: Clinical Implications of the REAL Classification (1999) (23)
HL-A antigen frequencies in myeloma. (1975) (22)
Cervical wart virus infection, intraepithelial neoplasia and carcinoma; an immunohistological study using a panel of monoclonal antibodies (1983) (22)
Isolation and characterization of human fetal macrophages from placenta. (1989) (22)
Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues. (2009) (21)
Dendritic reticulum cells in reactive lymph nodes and tonsils: an immunohistological study (1986) (21)
Immunohistological analysis of human lymphoid tissue by double immunoenzymatic labelling (2004) (21)
Immunofluorescent and FISH Analysis of Skin Biopsies (2004) (20)
Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections. (1990) (20)
The detection of membrane and cytoplasmic immunoglobulins in human leucocytes by immunoperoxidase staining. (1977) (20)
Immunohistological reactivity pattern of the anti‐cutaneous T‐cell lymphoma antibody BE2 (1986) (20)
TAL‐1 protein expression in vascular lesions (1997) (20)
Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material. (2007) (20)
Monoclonal antibody JC1: new reagent for studying cell proliferation. (1992) (19)
Immunohistochemical Analysis of Monoclonal Anti-B Cell Antibodies (1986) (19)
Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. (2005) (19)
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. (2009) (18)
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice? (2006) (18)
Diagnosis of acute myeloid leukaemia with the use of monoclonal anti‐neutrophil elastase (NP57) reactive with routinely processed biopsy samples (1989) (18)
Letter: Spinal-fluid lysozyme in diagnosis of central-nervous-system tumours. (1974) (18)
Subcellular localization of bcl-2 protein. (1992) (17)
Labeling of Multiple Cell Markers and mRNA Using Automated Apparatus (2008) (17)
Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia. (1996) (17)
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? (2010) (16)
Megakaryoblastic leukaemia and myelofibrosis complicating Fanconi anaemia. (2009) (16)
Immunohistochemical screening for oncogenic tyrosine kinase activation (1999) (16)
Leucocyte‐specific protein (LSP1) in malignant lymphoma and Hodgkin's disease (2003) (16)
Species conservation of the T cell lymphocyte CD2 cell surface antigen (1988) (16)
Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations (2012) (16)
Morphological and Phenotypic Features in Pediatric Large Cell Lymphoma and Their Correlation with ALK Expression and the t(2;5)(p23;q35) Translocation (2001) (15)
Relative expression of surface IgM, IgD and the Ig-associating alpha(mb-1) and beta(B-29) polypeptide chains. (1992) (14)
T-cell growth factor receptor (Tac-antigen) expression in cutaneous lymphoid infiltrates. (1986) (14)
Preferential localisation of human lymphocytes bearing y5 T cell receptors to the red pulp of the spleen. (14)
Ribosome‐associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia (2010) (14)
mb-1: a new marker for B-lineage lymphoblastic leukemia. (1993) (14)
Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas (2004) (14)
The Value of Immunocytochemistry in Differentiating High-Grade: Lymphoma from Other Anaplastic Tumours: A study of anaplastic tumours from 1940 to 1960. (1989) (13)
ALK-POSITIVE LYMPHOMA (1999) (13)
Immunocytochemical Characterization of Monoclonal Anti-Leucocyte Antibodies (1984) (13)
Role of immunohistochemistry in diagnosis of nasopharyngeal tumours. (1985) (12)
The characterization of two monoclonal anti‐keratin antibodies and their use in the study of epithelial disorders (1985) (12)
Induction of tyrosine phosphorylation in human B lineage cells by crosslinking MB-1 molecule of B cell receptor-related heterodimer complex. (1993) (12)
The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumours. (1985) (12)
Monoclonal antibodies to human cell surface antigens. (1979) (12)
Immunocytochemical analysis of cytocentrifuged fine needle aspirates. A study based on lung tumors aspirated in vitro. (1989) (11)
AN IMMUNOHISTOCHEMICAL STUDY OF TAL‐1 PROTEIN EXPRESSION IN LEUKAEMIAS AND LYMPHOMAS WITH A NOVEL MONOCLONAL ANTIBODY, 2TL 242 (1996) (11)
The use of monoclonal antibodies for histopathologic diagnosis of human malignancy. (1982) (11)
Specific Enzyme Treatment is Required for Individual Monoclonal Antibodies in Immunohistochemistry with Formalin Fixed Sections (1985) (11)
The Differential Diagnosis of Routinely Processed Anaplastic Tumors Using Monoclonal Antibodies (1985) (10)
Management of the hereditary coagulation disorders. (1971) (10)
Immunocytochemistry in the detection of bone marrow metastases in patients with primary lung cancer. (1986) (10)
T‐helper cell lymphoma involving the lymph nodes and skin a clinical, morphologic, and immunohistochemical analysis of five cases (1985) (10)
Immunochemical studies of antigenic  lymphoma‐associated proteins (2002) (9)
In situ immunological characterization of Langerhans cells with monoclonal antibodies: Comparison with other dendritic cells in skin and lymph nodes (2004) (9)
Leukaemia-associated antigens in man. Detection by antibodies in maternal sera. (1974) (9)
Reversible p53 expression in lung cancer (1992) (9)
The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders. (1990) (9)
Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages. (1985) (9)
Molecular cloning of bovine mb-1 cDNA. (1996) (8)
Measurement of kappa:lambda light chain ratios by haemagglutination techniques. (1975) (7)
Genotypic, phenotypic, and functional aspects of haematopoiesis (1987) (7)
The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-up. (1988) (6)
Hodgkin’s Disease and So-Called Malignant Histiocytosis: (1984) (6)
NPM-ALK expression as a diagnostic marker in cutaneous CD30 positive T-cell lymphoproliferative disorders (1998) (6)
Tyrosine phosphorylation in human lymphomas (2004) (6)
The expression of Bcl‐2 by proliferating cells varies in different categories of B‐cell lymphoma (2010) (6)
A new monoclonal antibody (JC159) that detects glycophorin A for the diagnosis of erythroleukaemia (1991) (5)
Cytokeratin expression in smooth muscle and smooth muscle tumours. (1987) (5)
Immuno-alkaline phosphatase labelling of haematological samples: technique and applications. (1985) (5)
Erratum: The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas (British Journal of Haematology (2005) 128 (333-342)) (2005) (5)
Immunosuppression and thrombosis in renal transplantation: an immunohistological study (1990) (5)
Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma (2006) (4)
Ultrastructural localization of human complement C3b receptors in the human kidney as determined by immunoperoxidase staining with the monoclonal antibody C3RTo5 (1982) (4)
Defining the molecular target of an antibody derived from nuclear extract of Jurkat cells using protein arrays. (2009) (4)
Immunocytochemical labeling of leukaemia samples with monoclonal antibodies by the APAAP procedure (1991) (3)
Disseminated intravascular thrombosis as the cause of ischaemic enterocolitis. (1976) (3)
Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells. (1986) (3)
Self-Tolerance in B-Cells from Different Lines of Lysozyme Double-Transgenic Mice (1989) (3)
From genes to antibodies: the antipeptide approach to the immunocytochemical study of human malignant lymphoproliferative diseases. (1991) (3)
Sensitivity of platelets to aspirin in von Willebrand's disease (1970) (3)
Innovations in immunohistochemistry for the haematopathologist. (2007) (2)
An immunoelectron microscopic study of human placenta using three monoclonal antibodies. (1983) (2)
Monocyte ingestion of IgG-coated erythrocytes from haemolysing and non-haemolysing subjects. (1976) (2)
ALK-1 antibody staining pattern in anaplastic large cell lymphoma (ALCL) and ALCL-Hodgkin's like (1997) (2)
Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies. (1985) (2)
Immunocytochemical Analysis of Lymphoid Lesions Using -Fine Needle Aspiration Biopsy. (1990) (2)
Improved detection of common translocation breakpoints in non-Hodgkins lymphomas by fluorescence in situ hybridization on routine paraffin embedded tissue samples. (2001) (2)
Subcellular Localization of bc/-2 Protein (1992) (1)
Intracellular lysozyme andlactoferrin in (1977) (1)
Lacking the 2; 5 Translocation A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and (2013) (1)
Therole ofimmunocytochemistry indiagnostic pathology (1987) (1)
Heterogeneity ofvascular endothelial cells with relevance todiagnosis ofvascular tumours (1992) (1)
Dysregulation of Pax5 Activity Contributes to the Extinction of the B-Cell Phenotype in Reed-Sternberg Cells (2008) (1)
BCL11AXL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells. (2005) (1)
Advances in Brief A New Variant Anaplastic Lymphoma Kinase ( ALK )-Fusion Protein ( ATIC-ALK ) in a Case of ALK-positive Anaplastic Large Cell Lymphoma 1 (2000) (1)
The immunohistological analysis of undecalcified human bone marrow trephine biopsies. Technical and diagnostic aspects. (1984) (1)
THE POLYMERASE CHAIN-REACTION IN PATHOLOGY (1989) (0)
DNA AND RNA STUDIES INTO THE NPM-ALK REARRANGEMENT IN KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA, DIAGNOSTIC APPLICATIONS (1994) (0)
Combined immunophenotyping and FISH for identification of cell lineages with the 5q-abnormality (1999) (0)
Kidney Liver * Lung Adrenal Thyroid Ovary Testis Skin Lymph node Tonsil Thymus Spleen Cerebrum and cerebellum Pancreas Glomerular capillaries Interstitial capillaries (2004) (0)
IMMUNOCYTOCHEMICAL STUDY OF THE BCL-2 GENE-PRODUCT (1990) (0)
A novel F-box protein is differentially expressed in hematopoietic malignancies. (2001) (0)
analysis of lymphoid tissue . use in the immunohistological dendritic reticulum cells and its antibody reactive with human Production of a monoclonal (0)
and leukemia: clinical value of their detection by immunocytochemistry Proteins encoded by genes involved in chromosomal alterations in lymphoma (2010) (0)
Sensitivity ofplatelets to aspirin in von Willebrand ' s disease Methods BLEEDING TIME EXPERIMENTS (0)
Expression ofintermediate filament proteins in normal anddiseased thyroid glands (1987) (0)
IMMUNOHISTOLOGICAL STUDY OF OSTEOCLASTS IN HUMAN-FETAL BONE (1986) (0)
anaplastic large-cell lymphoma Immune response to the ALK oncogenic tyrosine kinase in patients with (2013) (0)
A Quick Method for Identifying the Molecular Targets of Potentially Diagnostic New Monoclonal Antibodies Using Protein Array Technology. (2005) (0)
Heterogeneous expression of B cell‐associated markers in follicular lymphoma (2011) (0)
Tolerant Autoreactive B Lymphocytes in the Follicular Mantle Zone Compartment: Substrates for Receptor Editing and Reform (1993) (0)
Preferential localisation ofhumanlymphocytes bearing y5 T cell receptors totheredpulpofthe spleen. (1990) (0)
Morphology ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of (2013) (0)
Humanlung tumours may coexpressdifferent classes ofintermediate filaments (1986) (0)
Interfollicular large B-cells: a subpopulation that may give rise to human lymphomas (2003) (0)
IMMUNOPEROXIDASE STUDIES OF SKIN DISEASE (1977) (0)
The Authors’ Reply: We Agree (1986) (0)
II Preparation of Peroxidase:Antiperoxidase (PAP) Complexes for Immunohistological Labeling of (1982) (0)
リンパ腫のREAL分類 = Classification of human lymphoid neoplasms (1996) (0)
Erratum (2005) (0)
Monoclonal antibodies in diagnostic immunohistochemistry: edited by Mark R. Wick and Gene P. Siegal, Marcel Dekker Inc. 1988. $150.00 (x + 654 pages) ISBN 0 8247 7838 3 (1989) (0)
Short Communication Biochemical Detection of Novel Anaplastic Lymphoma Kinase Proteins in Tissue Sections of Anaplastic Large Cell Lymphoma (1999) (0)
EXPRESSION AND EPIGENETIC ANALYSIS OF KEY B-LINEAGE TRANSCRIPTIONAL PROGRAMMES IN HODGKIN/REED-STERNBERG CELLS (2009) (0)
CELL SUBPOPULATIONS IN HISTIOCYTOSIS X (1984) (0)
Lymphoproliferative Diseases and Monoclonal Gammopathy (1980) (0)
Immunoperoxidase staining ofsurface and intracellular immunoglobulin inhumanneoplastic lymphoid cells (1980) (0)
Lineage studies of 5q deletions using combined immunophenotyping & fish. (1999) (0)
Thedistribution ofmuramidase (lysozyme) in humantissues (1975) (0)
Newapproach toassessing lung tumoursinman (1986) (0)
cells Novel markers of normal and neoplastic human plasmacytoid dendritic (2011) (0)
An Immunohistological Study of Skin Tumours (1984) (0)
ANATOMICAL P ATHOLOGY (2012) (0)
Grant Writing Workshop for Environmental Justice (1995) (0)
Piris PRDM 1 / BLIMP-1 expression in multiple B and T-cell lymphoma (2006) (0)
DETECTING t(14;18) IN PARAFFIN-EMBEDDED LYMPHOMA TISSUE (1989) (0)
SUMMARY Thealkaline phosphatase-antialkaline phosphatase (APAAP)immunocytochemical staining technique was usedtolookforcirculating cells ofmegakaryocyte lineage inperipheral blood smearsfrom67casesofmyelodysplasia. Small numbers ofmicromegakaryocytes (2017) (0)
Sensitivity ofplatelets toaspirin invon Willebrand's disease (1970) (0)
The Value of Immunocytocherniistry in Differentiating HiLgh-Grade: Lymphoma from 0 ther Anaplastic (1989) (0)
Immunocytochemical labelling of haematological samples using monoclonal antibodies. (1985) (0)
Detection of Multiple Cell Molecules and mRNA (2008) (0)
and Localizes to Nuclear Structures The HRX Proto-oncogene Product Is Widely Expressed in Human Tissues (2013) (0)
Monoclonal antibody Leu-22. (1990) (0)
Clues to lymphoma's cellular origin (2006) (0)
CD68reactivity ofnon-macrophage derived tumours incytological specimens (1993) (0)
The Oncoprotein LMO2 Is Expressed in a Germinal Center B-Cell-Associated Pattern and Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David York Mason?

David York Mason is affiliated with the following schools:

David York Mason's Academic­Influence.com Rankings

David York Mason's Degrees

Why Is David York Mason Influential?

David York Mason's Published Works

Published Works

What Schools Are Affiliated With David York Mason?

David York Mason's AcademicInfluence.com Rankings